Peak Bio, Inc. – NASDAQ:PKBO

Add to watchlist

$0.54

+0.53

+5900%

Market closed

Open in 2 days

+73.08%

month

-76.13%

quarter

-98.91%

year

Market Cap	1.61M
Enterprise value	N/A

P/E	N/A
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	N/A
PEG ratio	N/A
EPS	-1.35

Revenue	N/A
EBITDA	-16.13M
Income	-25.68M
Revenue Q/Q	N/A
Revenue Y/Y	6.92%

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Peak Bio, Inc. (NASDAQ:PKBO): Profit margin
Sep 2022	0	-171.00K
Dec 2022	607.68K	-13.19M	-2171.02%
Mar 2023	13.85K	-6.37M	-46029.88%
Jun 2023	0	-5.94M

Peak Bio Financials Estimate

Q Y

Peak Bio, Inc. (NASDAQ:PKBO): Analyst Estimates
2025	924.78K	-28.33M	-3064.4%

Analysts Price target
Financials & Ratios estimates

Peak Bio, Inc. (NASDAQ:PKBO): Debt to assets
Sep 2022	57985967	2.38M	4.12%
Dec 2022	7529712	15.62M	207.5%
Mar 2023	2679140	17.05M	636.54%
Jun 2023	1795207	21.11M	1176.16%

Peak Bio, Inc. (NASDAQ:PKBO): Cash Flow
Sep 2022	1.64M	122.45K	-2.02M
Dec 2022	-6.83M	-142.24K	7.73M
Mar 2023	-1.44M	0	1.14M
Jun 2023	-1.23M	483.24K	883.62K

Peak Bio alternative data

Peak Bio, Inc. (NASDAQ:PKBO): Employee count
Aug 2023	21
Sep 2023	21
Oct 2023	21
Nov 2023	21
Dec 2023	21
Jan 2024	21
Feb 2024	21
Mar 2024	21
Apr 2024	21
May 2024	21
Jun 2024	21
Jul 2024	21

Peak Bio, Inc. (NASDAQ:PKBO): Insider trades (number of shares)
Period	Buy	Sel
Aug 2023	93250	0
Sep 2023	295350	0

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Purchase	27 Sep 2023	LAMOND STEPHEN J director, officer: See Remarks director, officer: See Remarks	Common Stock	2,600	$0.13	$338
Purchase	26 Sep 2023	LAMOND STEPHEN J director, officer: See Remarks director, officer: See Remarks	Common Stock	3,000	$0.13	$390
Purchase	21 Sep 2023	HUH HOYOUNG director, 10 percent owner: director, 10 percent owner:	Common Stock	45,000	$0.19	$8,550
Purchase	20 Sep 2023	HUH HOYOUNG director, 10 percent owner: director, 10 percent owner:	Common Stock	30,000	$0.19	$5,700
Purchase	19 Sep 2023	HUH HOYOUNG director, 10 percent owner: director, 10 percent owner:	Common Stock	50,000	$0.21	$10,350
Purchase	18 Sep 2023	LAMOND STEPHEN J director, officer: See Remarks director, officer: See Remarks	Common Stock	2,500	$0.23	$575
Purchase	18 Sep 2023	LAMOND STEPHEN J director, officer: See Remarks director, officer: See Remarks	Common Stock	2,500	$0.23	$575
Purchase	15 Sep 2023	LAMOND STEPHEN J director, officer: See Remarks director, officer: See Remarks	Common Stock	11,750	$0.27	$3,173
Purchase	15 Sep 2023	LAMOND STEPHEN J director, officer: See Remarks director, officer: See Remarks	Common Stock	26,000	$0.28	$7,150
Purchase	15 Sep 2023	HUH HOYOUNG director, 10 percent owner: director, 10 percent owner:	Common Stock	25,000	$0.27	$6,625

Frequently Asked Questions (FAQ)

What's the price of Peak Bio stock today?

One share of Peak Bio stock can currently be purchased for approximately $0.54.
When is Peak Bio's next earnings date?

Unfortunately, Peak Bio's (PKBO) next earnings date is currently unknown.
Does Peak Bio pay dividends?

No, Peak Bio does not pay dividends.
How much money does Peak Bio make?

Peak Bio has a market capitalization of 1.61M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 39.46% to 367.88K US dollars.
What is Peak Bio's stock symbol?

Peak Bio, Inc. is traded on the NASDAQ under the ticker symbol "PKBO".
What is Peak Bio's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Peak Bio?

Shares of Peak Bio can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does Peak Bio have?

As Jul 2024, Peak Bio employs 21 workers.
When Peak Bio went public?

Peak Bio, Inc. is publicly traded company for more then 4 years since IPO on 15 Mar 2021.
What is Peak Bio's official website?

The official website for Peak Bio is peak-bio.com.
Where are Peak Bio's headquarters?

Peak Bio is headquartered at 3350 W Bayshore Rd., Palo Alto, CA.
How can i contact Peak Bio?

Peak Bio's mailing address is 3350 W Bayshore Rd., Palo Alto, CA and company can be reached via phone at +65 05499103.

Peak Bio, Inc.

peak-bio.com

Exchange:

NASDAQ

Full time employees:

Industry:

Biotechnology

Sector:

Healthcare

Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics addressing unmet needs in the areas of oncology and inflammation. The company's proprietary toxin, PH-1 or Thailanstatin, a spliceosome modulator is being used to generate its first pipeline of novel ADC product candidates to address unmet needs in cancer patients. Its lead product candidate, PHP-303, is a small molecule awaiting Phase II dose clinical study in the orphan disease Alpha1 anti-trypsin deficiency (AATD). The company is based in Palo Alto, California.

+65 05499103

3350 W Bayshore Rd.
Palo Alto, CA 94303

CIK: 0001834645
ISIN: US70470P1084
CUSIP: 70470P108